Results 81 to 90 of about 8,462 (183)

Testing for LTBI: more of the same or a step forward?

The International Journal of Tuberculosis and Lung Disease, 2018
van Leth, Frank, Sester, Martina
openaire   +3 more sources

Exposure Time to a Tuberculosis Index Case as a Marker of Infection in Immigrant Populations

Pathogens
Background: Exposure time to a tuberculosis (TB) index case may be a marker of a recent latent tuberculosis infection (LTBI) risk. The aim of this study was to determine the LTBI risk involved in immigrant contact based on exposure time to pulmonary TB ...
Sofia Godoy, Miquel Alsedà, Ignasi Parrón, Joan-Pau Millet, Joan A. Caylà, Núria Follia, Monica Carol, Angels Orcau, Diana Toledo, Gloria Ferrús, Pere Plans, Irene Barrabeig, Laura Clotet, Angela Domínguez, Jaume March-Llanes, Pere Godoy, on behalf of the Transmission of Tuberculosis in Catalonia (Spain) Working Group   +16 more
doaj   +1 more source

Kürzere Chemoprävention bei Kindern mit LTBI [PDF]

Pneumologie, 2018
openaire   +1 more source

Is There Value in Performing Yearly Screening for Latent Tuberculosis Infection by Interferon-Gamma Release Assay Among Patients Living With HIV in Non-Endemic Settings? [PDF]

Open Forum Infect Dis
Foppiano Palacios C, Achhra A, Barakat L, Virata M, Hao R, Baxter J, Malinis M.   +6 more
europepmc   +1 more source

Detection of Latent Tuberculosis Infection in Patients with Rheumatological Diseases Who Receive Immunosuppressive Therapy. [PDF]

Diagnostics (Basel)
Starshinova A, Sabirova A, Maslyanskiy A, Grigorieva I, Sharipov R, Tukfatullin R, Panteleev A, Nazarenko M, Kudlay D.   +8 more
europepmc   +1 more source

Mycobacterium tuberculosis in patients with hematologic malignancies in a low-risk setting

IJTLD Open
L. Mezzadri, A. Tebaldi, V. Ravasio, D. Ripamonti   +3 more
doaj   +1 more source

Study on the safety evaluation of latent tuberculosis treatment in high‑risk groups for tuberculosis development: Study protocol for a multi‑center prospective observational cohort study in Korea (STEP-TB). [PDF]

PLoS One
Hwang Y, Park Y, Kim HW, Jeong SY, Jeong Y, Stagg HR, Kim JS, Min J.   +7 more
europepmc   +1 more source

Exploration of common immune mechanisms and hub genes in latent and active tuberculosis infection. [PDF]

Front Cell Infect Microbiol
Yang X, Chang M, Liu F.
europepmc   +1 more source

A QuantiFERON^®-TB Gold Plus-Based Model for Predicting Latent Tuberculosis Infection in Patients with Diabetes. [PDF]

Infect Drug Resist
Zhou J, Lin X, Yu Y, Zhang Y, Qiu L, Lin Z, Jiang X, Shi J.   +7 more
europepmc   +1 more source

A proteome-wide atlas of humoral immunity to <i>Mycobacterium tuberculosis</i> across the spectrum of disease. [PDF]

Front Immunol
Khan MZ, Irvine EB, Cizmeci D, Davies LRL, Randall AZ, Pablo J, Vidal SJ, Lasrado N, Darrah PA, Hsiao JC, Mann C, Nair S, Grace PS, Fontana L, Juelg B, Barouch DH, Restrepo BI, Roederer M, Seder RA, Wallis RS, Churchyard G, Stein CM, Boom WH, Campo JJ, Alter G.   +24 more
europepmc   +1 more source